Overall, both SAM and curcumin (and their combination) revealed to be able to downregulate the SCNN1A and SCNN1B gene expression in both CFBE (Fig. 4A and B) and primary CF HBE (Fig. 5A and B). This evidence concerns the gene SCNN1A and cystic fibrosis.